• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于两阶段病例对照研究中第二阶段规划的极小极大设计。

Minmax designs for planning the second phase in a two-phase case-control study.

作者信息

Schill W, Wild P

机构信息

Bremer Institut für Präventionsforschung und Sozialmedizin (BIPS) und Institut für Statistik, Universität Bremen, Germany.

出版信息

Stat Med. 2006 May 30;25(10):1646-59. doi: 10.1002/sim.2307.

DOI:10.1002/sim.2307
PMID:16158403
Abstract

Two-phase designs, in which a subsample with validation or complete information data is sampled stratified both on outcome and covariate from a first-phase study with incomplete data, have been proposed over 10 years ago and have been proven to result in efficient estimates with respect to standard designs. The efficiency depends, however, on the sampling fractions within each stratum. Our aim is to present a strategy for obtaining an optimized design, i.e. sampling fractions, that makes use of available phase-one data of an existing case-control study considered as the first-phase sample when the focus is on estimating a parameter vector. No global optimal design exists and local optimal designs depend on scenarios comprising the true disease model and the association between the phase-one and phase-two information. We develop an admissibility test that rejects scenarios inconsistent with the phase-one data and, for the selected scenarios, determine a minmax D- or A-optimal design that protects against worst-case scenarios. This work is applied on two examples.

摘要

两阶段设计在十多年前就已被提出,即在第一阶段研究数据不完整的情况下,从其中抽取一个包含验证或完整信息数据的子样本,该子样本在结局和协变量上均进行分层抽样,并且已被证明相对于标准设计能得到有效估计。然而,效率取决于各层内的抽样比例。我们的目标是提出一种获得优化设计(即抽样比例)的策略,当重点是估计参数向量时,该策略利用现有病例对照研究的可用第一阶段数据作为第一阶段样本。不存在全局最优设计,局部最优设计取决于包括真实疾病模型以及第一阶段和第二阶段信息之间关联的场景。我们开发了一种可容许性检验,用于拒绝与第一阶段数据不一致的场景,并针对选定的场景确定一个最小最大D最优或A最优设计,以防范最坏情况。这项工作应用于两个示例。

相似文献

1
Minmax designs for planning the second phase in a two-phase case-control study.用于两阶段病例对照研究中第二阶段规划的极小极大设计。
Stat Med. 2006 May 30;25(10):1646-59. doi: 10.1002/sim.2307.
2
A planning tool for two-phase case-control studies.一种用于两阶段病例对照研究的规划工具。
Comput Methods Programs Biomed. 2007 Nov;88(2):175-81. doi: 10.1016/j.cmpb.2007.08.002. Epub 2007 Sep 14.
3
Including sampling and phenotyping costs into the optimization of two stage designs for genomewide association studies.将抽样和表型分型成本纳入全基因组关联研究两阶段设计的优化过程中。
Genet Epidemiol. 2007 Dec;31(8):844-52. doi: 10.1002/gepi.20245.
4
A simulation study of control sampling methods for nested case-control studies of genetic and molecular biomarkers and prostate cancer progression.针对遗传和分子生物标志物与前列腺癌进展的巢式病例对照研究的对照抽样方法的模拟研究。
Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):706-11. doi: 10.1158/1055-9965.EPI-08-0839. Epub 2009 Mar 3.
5
The analysis of case-control studies under validation subsampling.验证性子抽样下的病例对照研究分析
Eur J Clin Nutr. 1993 Oct;47 Suppl 2:S34-41.
6
Update of potency factors for asbestos-related lung cancer and mesothelioma.石棉相关肺癌和间皮瘤效力因子的更新。
Crit Rev Toxicol. 2008;38 Suppl 1:1-47. doi: 10.1080/10408440802276167.
7
Robust and efficient design of experiments for the Monod model.莫诺德模型稳健且高效的实验设计
J Theor Biol. 2005 Jun 21;234(4):537-50. doi: 10.1016/j.jtbi.2004.12.011.
8
Optimal adaptive design in clinical drug development: a simulation example.临床药物开发中的最优适应性设计:一个模拟示例。
J Clin Pharmacol. 2007 Oct;47(10):1231-43. doi: 10.1177/0091270007308033.
9
Logistic regression methods for retrospective case-control studies using complex sampling procedures.使用复杂抽样程序的回顾性病例对照研究的逻辑回归方法。
Biometrics. 1986 Dec;42(4):955-60.
10
Estimating interaction between genetic and environmental risk factors: efficiency of sampling designs within a cohort.估计遗传和环境风险因素之间的相互作用:队列中抽样设计的效率
Epidemiology. 2008 Jan;19(1):83-93. doi: 10.1097/EDE.0b013e31815c4d0e.

引用本文的文献

1
A two-stage phase II clinical trial design with nested criteria for early stopping and efficacy.一种具有早期终止和疗效的嵌套标准的两阶段II期临床试验设计。
Pharm Stat. 2019 Nov;18(6):700-713. doi: 10.1002/pst.1965. Epub 2019 Sep 10.
2
The cost-effectiveness of reclassification sampling for prevalence estimation.重新分类抽样在患病率估计中的成本效益。
PLoS One. 2012;7(2):e32058. doi: 10.1371/journal.pone.0032058. Epub 2012 Feb 13.
3
Flexible Two-Phase studies for rare exposures: Feasibility, planning and efficiency issues of a new variant.
针对罕见暴露的灵活两阶段研究:一种新变体的可行性、规划与效率问题
Epidemiol Perspect Innov. 2008 Oct 1;5:4. doi: 10.1186/1742-5573-5-4.